Mild cognitive impairment represents early-stage Alzheimer disease

Archives of Neurology

Volumn 58, Issue 3, 2001, Pages 397-405

  Morris, J C ^a   Storandt, M ^a   Miller, J P ^a   McKeel, D W ^a   Price, J L ^a   Rubin, E H ^a   Berg, L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY;

EID: 0035099984     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.3.397     Document Type: Article

References (61)

1. Mild cognitive impairment
2. Mild cognitive impairment in the elderly: Predictors of dementia
3. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
4. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
5. Questionable dementia: Clinical course and predictors of outcome
6. Progression to dementia in patients with isolated memory loss
7. Do subjective memory complaints precede dementia: A three-year follow-up of patients with supposed "benign senescent forgetfulness."
8. Predicting conversion to Alzheimer disease using standardized clinical information
9. Predictors of cognitive change in middle-aged and older adults with memory loss
10. Mild cognitive impairment: Potential pharmacological treatment options
11. The Clinical Dementia Rating (CDR): Current version and scoring rules
12. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinicians
13. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease
14. Detection of mild dementia in community surveys
15. Memory evaluation in Alzheimer's disease: Caregivers, appraisals and objective testing
16. Screening for early dementia using memory complaints from patients and relatives
17. The value of informant vs. individual's complaints of memory impairment in early dementia
18. Methods of screening for dementia: A meta-analysis of studies comparing an informant questionnaire with a brief cognitive test
19. The prediction of Alzheimer disease
20. The prognosis in Alzheimer's disease; "how far" rather than "how fast" best predicts the course
21. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part IV: Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
22. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old
23. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging
24. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
25. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
26. Mild senile dementia of Alzheimer type (SDAT): Research diagnostic criteria, recruitment, and description of a study population
27. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
28. Validation of clinical diagnostic criteria for Alzheimer's disease
29. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
30. Validation of a short orientation-memoryconcentration test of cognitive impairment
31. A new clinical scale for the staging of dementia
32. Reliability of the Washington University Clinical Dementia Rating
33. Reliability of clinical nurse specialists in the staging of dementia
34. Clinical dementia rating (CDR) training and reliability protocol: The Alzheimer Disease Cooperative Study Unit experience
35. Mild senile dementia of the Alzheimer type, 2: Longitudinal assessment
36. Retrospective postmortem dementia assessment: Validation of a new clinical interview to assist neuropathologic study
37. Restriction isotyping of human apolipoprotein E by gone amplification and cleavage with Hhal
38. Very mild senile dementia of the Alzheimer type, II: Psychometric test performance
39. An analysis of certain psychological tests used in the evaluation of brain injury
40. Speed functions, vocabulary ability, and age
41. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older
42. Interlaboratory histopathologic assessment of Alzheimer neuropathology: Different methodologies yield comparable diagnostic results
43. Diagnosis of Alzheimer's disease
44. Health, functional, and psychological outcomes among older persons with chronic dizziness
45. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: Clinical and neuropsychological assessment of Alzheimer's disease
46. Memory function in normal aging
47. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort
48. Immediate and delayed prose recall among normal and demented adults
49. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease
50. A prospective study of cognitive function and onset of dementia in cognitively healthy elders
51. The role of APOE e4 in modulating effects of other risk factors for cognitive decline in elderly persons
52. Clinical issues relating to the diagnosis of mild dementia in a British community survey
53. Prevalence and severity of cognitive impairment with and without dementia in an elderly population
54. Cognitive impairment without dementia in older people: Prevalence, vascular risk factors, impact on disability: The Italian longitudinal study on aging
55. Clinical trials in Alzheimer's disease: The debate on the use of placebo controls